Genetic switches designed for eukaryotic cells and controlled by serine integrases
Mayna da Silveira Gomide, Thais Torquato Sales, Luciana Rodrigues Carvalho Barros, Cintia Gomez Limia, Marco A. de Oliveira, Lílian H. Florentino, L. M. G. Barros, Maria L. Robledo, G. Pinheiro Coelho José, Mariana S. M. Almeida, Rayane Nunes Lima, Stevens K. Rehen, Cristiano Lacorte, Eduardo O. Melo, André M. Murad, Martín Bonamino, Cíntia Marques Coelho, Elíbio Rech
Abstract
Recently, new serine integrases have been identified, increasing the possibility of scaling up genomic modulation tools. Here, we describe the use of unidirectional genetic switches to evaluate the functionality of six serine integrases in different eukaryotic systems: the HEK 293T cell lineage, bovine fibroblasts and plant protoplasts. Moreover, integrase activity was also tested in human cell types of therapeutic interest: peripheral blood mononuclear cells (PBMCs), neural stem cells (NSCs) and undifferentiated embryonic stem (ES) cells. The switches were composed of plasmids designed to flip two different genetic parts driven by serine integrases. Cell-based assays were evaluated by measurement of EGFP fluorescence and by molecular analysis of attL/attR sites formation after integrase functionality. Our results demonstrate that all the integrases were capable of inverting the targeted DNA sequences, exhibiting distinct performances based on the cell type or the switchable genetic sequence. These results should support the development of tunable genetic circuits to regulate eukaryotic gene expression.